The purpose of this task order is to procure storage and stability of antigens and adjuvants from prior contracts for department of health and human services under IDIQ contract 75A50122D00002…
Ended Awarded Last action
- Contract number
- 75A50123F61006
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $2,045,697
Award facts
- Contract value 100% obligated
- $2,045,696.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $43,287 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $20,984 | |
| Other Administrative Action | $746,119 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,235,307 |
About this award
This federal contract award, identified as 75A50122D00002|75A50123F61006, is a delivery order under an Indefinite Delivery Indefinite Quantity (IDIQ) contract with the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The purpose of this $2,045,696.98 firm-fixed-price contract is to procure storage and stability services for antigens and adjuvants from prior contracts during the second base period year. The prime contractor is Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company that specializes in vaccines, antivirals, and other medical countermeasures. This contract does not have a set-aside designation and is set to expire on February 21, 2024. Glaxosmithkline has been awarded multiple federal contracts and grants, including Indefinite Delivery Contracts with the Centers for Disease Control and Prevention and the Department of Veterans Affairs for vaccine procurement.
Description
The purpose of this task order is to procure storage and stability of antigens and adjuvants from prior contracts for department of health and human services under IDIQ contract 75A50122D00002 during base period year 2.
Quick answers
Who was awarded contract 75A50123F61006?
75A50123F61006 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on February 22, 2023.
How much is contract 75A50123F61006 worth?
The government has obligated $2,045,697 on 75A50123F61006.
Is contract 75A50123F61006 an order under another contract?
Yes. 75A50123F61006 is a delivery order under 75A50122D00002, an indefinite delivery contract.
Was contract 75A50123F61006 competed?
The extent of competition for 75A50123F61006 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award